You are here

  • Home
  • Archive
  • Volume 107, Issue 6
  • Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry

Article metrics

Article menu

Download PDFPDF

Clinical science
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry

 

Online download statistics by month:

Online download statistics by month: January 2022 to August 2023

AbstractFullPdf
Jan 2022763758360
Feb 2022186618641387
Mar 2022194619441514
Apr 202226726854
May 202221221428
Jun 202225626023
Jul 202221822030
Aug 202222722713
Sep 202218918924
Oct 202216916926
Nov 202222322223
Dec 202220320522
Jan 20231541588
Feb 202311111114
Mar 20231601638
Apr 202315616010
May 202341641935
Jun 202333132945
Jul 202316015728
Aug 2023888716
Total811581243668